CVS Health Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
FBR Capital Remains Buyers of CVS Health (CVS) Following 'Solid' Quarter
August 2, 2016 2:16 PM EDTFBR Capital analyst Steven Halper reiterated an Outperform rating and $120 price target on CVS Health (NYSE: CVS) following a 'solid' Q2. The firm remains buyers of the stock.
Halper commented, "On August 2, CVS reported strong 2Q16 results with the PBM segment performing slightly better... More
CVS Health (CVS) Tops Q2 EPS by 2c; Boosts FY16 EPS Outlook
August 2, 2016 6:56 AM EDTCVS Health (NYSE: CVS) reported Q2 EPS of $1.32, $0.02 better than the analyst estimate of $1.30. Revenue for the quarter came in at $43.7 billion versus the consensus estimate of $44.28 billion.
Same store sales increased 2.1% versus the second quarter of 2015. Pharmacy same store sales rose 3.9% and... More
